Regenerative Technology Treats Acute and Chronic Wounds
|
By HospiMedica International staff writers Posted on 11 Feb 2020 |
|
Image: A sheet of the StimLabs Corplex allograft (Photo courtesy of Stimlabs)
An allograft made of dehydrated human umbilical cord tissue serves as a barrier membrane over acute and chronic wounds.
The StimLabs (Roswell, GA, USA) Corplex allograft is intended to facilitate the repair, reconstruction, replacement, or supplementation of injured tissue, by providing a robust matrix and protective barrier during wound remodeling. It is supplied in a sheet format for use in patients with chronic or acute wounds, especially tunneling wounds where a thicker sheet is warranted. Corplex complements StimLabs' portfolio of products, which includes Ascent, made of dehydrated cells and cellular components retained from amniotic fluid in an injectable format; and Revita, an intact human placental membrane allograft that preserves all layers of the native tissue in a shelf-stable format.
Corplex preserves structural umbilical cord tissue constituents using StimLabs’ patent-pending Clearify process, which retains key extracellular matrix (ECM) components, such as collagens, proteoglycans, and glycosaminoglycans, from both the epithelial layer and the Wharton's Jelly section of the umbilical cord tissue, while effectively cleaning and terminally sterilizing the graft. Corplex is shelf-stable for up to five years and is offered in various sheet sizes (15 mm, 2x2 cm, 2x3 cm, and 3x5 cm).
“Since StimLabs' inception, it's been our promise to deliver more targeted approaches to influence healing through accessibility, ease of use, and effectiveness, to ultimately improve patient outcomes,” said Sarah Griffiths, PhD, VP of Research and Development at StimLabs. “We've worked diligently to ensure these patent-pending processes and products are another step towards that aspiration. We're excited to continue pushing our product portfolio boundaries to more effectively meet the needs of both patients and providers.”
The umbilical cord (UC) is an essential part of the placenta, forming within the first weeks of gestation by the enclosure of blood vessels into a bulk of mucous connective tissue, named Wharton's jelly, and lined by the umbilical epithelium. The cells populating each component of the cord--Wharton's jelly, the lining epithelium, the sub-amnion layer, the perivascular region, and the blood vessels--are a reservoir of progenitor populations which are collectively grouped as mesenchymal stem cells (MSCs), which can differentiate towards mature cell types belonging to all the three germ layers.
Related Links:
StimLabs
The StimLabs (Roswell, GA, USA) Corplex allograft is intended to facilitate the repair, reconstruction, replacement, or supplementation of injured tissue, by providing a robust matrix and protective barrier during wound remodeling. It is supplied in a sheet format for use in patients with chronic or acute wounds, especially tunneling wounds where a thicker sheet is warranted. Corplex complements StimLabs' portfolio of products, which includes Ascent, made of dehydrated cells and cellular components retained from amniotic fluid in an injectable format; and Revita, an intact human placental membrane allograft that preserves all layers of the native tissue in a shelf-stable format.
Corplex preserves structural umbilical cord tissue constituents using StimLabs’ patent-pending Clearify process, which retains key extracellular matrix (ECM) components, such as collagens, proteoglycans, and glycosaminoglycans, from both the epithelial layer and the Wharton's Jelly section of the umbilical cord tissue, while effectively cleaning and terminally sterilizing the graft. Corplex is shelf-stable for up to five years and is offered in various sheet sizes (15 mm, 2x2 cm, 2x3 cm, and 3x5 cm).
“Since StimLabs' inception, it's been our promise to deliver more targeted approaches to influence healing through accessibility, ease of use, and effectiveness, to ultimately improve patient outcomes,” said Sarah Griffiths, PhD, VP of Research and Development at StimLabs. “We've worked diligently to ensure these patent-pending processes and products are another step towards that aspiration. We're excited to continue pushing our product portfolio boundaries to more effectively meet the needs of both patients and providers.”
The umbilical cord (UC) is an essential part of the placenta, forming within the first weeks of gestation by the enclosure of blood vessels into a bulk of mucous connective tissue, named Wharton's jelly, and lined by the umbilical epithelium. The cells populating each component of the cord--Wharton's jelly, the lining epithelium, the sub-amnion layer, the perivascular region, and the blood vessels--are a reservoir of progenitor populations which are collectively grouped as mesenchymal stem cells (MSCs), which can differentiate towards mature cell types belonging to all the three germ layers.
Related Links:
StimLabs
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Autoclavable Camera System
Precision AC
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
Channels
Artificial Intelligence
view channel
AI-Powered Algorithm to Revolutionize Detection of Atrial Fibrillation
Atrial fibrillation (AFib), a condition characterized by an irregular and often rapid heart rate, is linked to increased risks of stroke and heart failure. This is because the irregular heartbeat in AFib... Read more
AI Diagnostic Tool Accurately Detects Valvular Disorders Often Missed by Doctors
Doctors generally use stethoscopes to listen for the characteristic lub-dub sounds made by heart valves opening and closing. They also listen for less prominent sounds that indicate problems with these valves.... Read more
Surgical Techniques
view channel
Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
The kidneys are essential organs that handle critical bodily functions, including waste elimination and blood pressure regulation. Often referred to as the silent organ because they typically do not manifest... Read more
Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
Hyperspectral imaging (HSI) is an advanced technique that captures and processes information across a given electromagnetic spectrum. Near-infrared hyperspectral imaging (NIR-HSI) has particularly gained... Read more
Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
Electric nerve implants serve dual functions: they can either stimulate or block signals in specific nerves. For example, they may alleviate pain by inhibiting pain signals or restore movement in paralyzed... Read more
Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
During brain surgery, neurosurgeons need to identify and preserve regions responsible for critical functions while removing harmful tissue. Traditionally, neurosurgeons rely on a team of electrophysiologists,... Read morePatient Care
view channel
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read more
Health IT
view channel
Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
Top industry experts have underscored the immediate requirement for healthcare systems and hospitals to respond to severe cost and margin pressures. Close to half of U.S. hospitals ended 2022 in the red... Read more
AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
For healthcare organizations, optimizing operating room (OR) utilization during prime time hours is a complex challenge. Surgeons and clinics face difficulties in finding available slots for booking cases,... Read more
AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
Screening for common cancers like breast, cervix, and prostate cancer relies on relatively simple and highly effective techniques, such as mammograms, Pap smears, and blood tests. These methods have revolutionized... Read morePoint of Care
view channel
Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing
Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Point of Care HIV Test Enables Early Infection Diagnosis for Infants
Early diagnosis and initiation of treatment are crucial for the survival of infants infected with HIV (human immunodeficiency virus). Without treatment, approximately 50% of infants who acquire HIV during... Read more
Whole Blood Rapid Test Aids Assessment of Concussion at Patient's Bedside
In the United States annually, approximately five million individuals seek emergency department care for traumatic brain injuries (TBIs), yet over half of those suspecting a concussion may never get it checked.... Read more
New Generation Glucose Hospital Meter System Ensures Accurate, Interference-Free and Safe Use
A new generation glucose hospital meter system now comes with several features that make hospital glucose testing easier and more secure while continuing to offer accuracy, freedom from interference, and... Read moreBusiness
view channel
Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
Johnson & Johnson (New Brunswick, N.J., USA) and Shockwave Medical (Santa Clara, CA, USA) have entered into a definitive agreement under which Johnson & Johnson will acquire all of Shockwave’s... Read more
